Proceedings of a workshop on DNA adducts: Biological significance and applications to risk assessment Washington, DC, April 13–14, 2004
- 作者：Miriam Sander ; Jean Cadet ; Daniel A. Casciano ; Sheila M. Galloway ; Lawrence J. Marnett ; Raymond F. Novak ; Syril D. Pettit ; R. Julian Preston ; Julie A. Skare ; Gary M. Williams et al.
- 关键词：Risk assessment ; DNA ; DNA adducts ; DNA damage ; Workshop report
- 刊名：Toxicology and Applied Pharmacology
- 出版年：2005
- 期刊代码：58_0041008x
- 类别：pha
- 出版时间：2005
- 卷：208
- 期：1
- 页码：1-20
- 文件大小：642 K
摘要
In April 2004, the Health and Environmental Sciences Institute, a branch of the International Life Sciences Institute, with support from the National Institute of Environmental Health Sciences, organized a workshop to discuss the biological significance of DNA adducts. Workshop speakers and attendees included leading international experts from government, academia, and industry in the field of adduct detection and interpretation. The workshop initially examined the relationship between measured adduct levels in the context of exposure and dose. This was followed by a discussion on the complex response of cells to deal with genotoxic insult in complex, interconnected, and interdependent repair pathways. One of the major objectives of the workshop was to address the recurring question about the mechanistic and toxicological relevance of low-concentration measured adducts and the presentations in the session entitled “Can low levels of DNA adducts predict adverse outcomes?ȁd; served as catalysts for further discussions on this subject during the course of the workshop. Speakers representing the regulatory community and industry reviewed the value, current practices, and limitations of utilizing DNA adduct data in risk assessment and addressed a number of practical questions pertaining to these issues. While no consensus statement emerged on the biological significance of low levels of DNA adducts, the workshop concluded by identifying the need for more experimental data to address this important question. One of the recommendations stemming from this workshop was the need to develop an interim “decision-logicȁd; or framework to guide the integration of DNA adduct data in the risk assessment process. HESI has recently formed a subcommittee consisting of experts in the field and other key stakeholders to address this recommendation as well as to identify specific research projects that could help advance the understanding of the biological significance of low levels of DNA adducts.